Hirtle Callaghan Co Lowers stake in Mead Johnson Nutrition CO (MJN)

Mead Johnson Nutrition CO (MJN) : Hirtle Callaghan Co reduced its stake in Mead Johnson Nutrition CO by 29.57% during the most recent quarter end. The investment management company now holds a total of 798 shares of Mead Johnson Nutrition CO which is valued at $70,455 after selling 335 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on Aug 2, 2016.Mead Johnson Nutrition CO makes up approximately 0.01% of Hirtle Callaghan Co’s portfolio.

Other Hedge Funds, Including , Mitsubishi Ufj Kokusai Asset Management Ltd. reduced its stake in MJN by selling 685 shares or 2.39% in the most recent quarter. The Hedge Fund company now holds 27,927 shares of MJN which is valued at $2,465,675. Mead Johnson Nutrition CO makes up approx 0.06% of Mitsubishi Ufj Kokusai Asset Management Ltd.’s portfolio.Hudock Capital Group boosted its stake in MJN in the latest quarter, The investment management firm added 1 additional shares and now holds a total of 149 shares of Mead Johnson Nutrition CO which is valued at $13,155. Mead Johnson Nutrition CO makes up approx 0.01% of Hudock Capital Group’s portfolio. Cibc World Markets added MJN to its portfolio by purchasing 2,691 company shares during the most recent quarter which is valued at $247,195.Fox Run Management L.l.c. reduced its stake in MJN by selling 5,500 shares or 67.9% in the most recent quarter. The Hedge Fund company now holds 2,600 shares of MJN which is valued at $237,224. Mead Johnson Nutrition CO makes up approx 0.11% of Fox Run Management L.l.c.’s portfolio.Hexavest reduced its stake in MJN by selling 19,848 shares or 3.71% in the most recent quarter. The Hedge Fund company now holds 515,718 shares of MJN which is valued at $47,033,482. Mead Johnson Nutrition CO makes up approx 0.70% of Hexavest’s portfolio.

Mead Johnson Nutrition CO opened for trading at $87.68 and hit $88.31 on the upside on Monday, eventually ending the session at $87.89, with a gain of 0.31% or 0.27 points. The heightened volatility saw the trading volume jump to 11,49,208 shares. Company has a market cap of $16,230 M.

On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.

Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *